These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 2926567

  • 1. Use of subcutaneous recombinant human erythropoietin in children undergoing continuous cycling peritoneal dialysis.
    Sinai-Trieman L, Salusky IB, Fine RN.
    J Pediatr; 1989 Apr; 114(4 Pt 1):550-4. PubMed ID: 2926567
    [Abstract] [Full Text] [Related]

  • 2. Subcutaneous recombinant human erythropoietin in children with renal anemia on continuous ambulatory peritoneal dialysis.
    Aufricht C, Balzar E, Steger H, Lothaller MA, Frenzel K, Kohlhauser C, Kiss H, Khoss AE, Kernova T.
    Acta Paediatr; 1993 Nov; 82(11):959-62. PubMed ID: 8111178
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of once- versus thrice-weekly subcutaneous recombinant human erythropoietin in children receiving continuous cycling peritoneal dialysis.
    Ongkingco JR, Ruley EJ, Turner ME, Fragale MR.
    Am J Nephrol; 1994 Nov; 14(1):14-8. PubMed ID: 8017476
    [Abstract] [Full Text] [Related]

  • 4. Effect of hyperparathyroidism on response to erythropoietin in children on dialysis.
    Belsha CW, Berry PL.
    Pediatr Nephrol; 1998 May; 12(4):298-303. PubMed ID: 9655362
    [Abstract] [Full Text] [Related]

  • 5. Low-dose erythropoietin is effective and safe in children on continuous ambulatory peritoneal dialysis.
    Yalçinkaya F, Tümer N, Cakar N, Ozkaya N.
    Pediatr Nephrol; 1997 Jun; 11(3):350-2. PubMed ID: 9203190
    [Abstract] [Full Text] [Related]

  • 6. Treatment of the anemia of chronic renal failure with subcutaneous recombinant human erythropoietin.
    Watson AJ, Gimenez LF, Cotton S, Walser M, Spivak JL.
    Am J Med; 1990 Oct; 89(4):432-5. PubMed ID: 2220877
    [Abstract] [Full Text] [Related]

  • 7. Weekly subcutaneous recombinant human erythropoietin corrects anemia of progressive renal failure.
    Zappacosta AR, Perras ST, Bell A.
    Am J Med; 1991 Sep; 91(3):229-32. PubMed ID: 1892142
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics and hematologic response to subcutaneous administration of recombinant human erythropoietin in children undergoing long-term peritoneal dialysis: a multicenter study.
    Montini G, Zacchello G, Perfumo F, Edefonti A, Bassi S, Cantaluppi A, Sarchi C, Cazzin M, Ferrari V, Boccazzi A.
    J Pediatr; 1993 Feb; 122(2):297-302. PubMed ID: 8429450
    [Abstract] [Full Text] [Related]

  • 9. Effect of erythropoietin in continuous ambulatory peritoneal dialysis patients: comparison between intravenous and intraperitoneal administration.
    Nasu T, Mitui H, Shinohara Y, Hayashida S, Ohtuka H.
    Perit Dial Int; 1992 Feb; 12(4):373-7. PubMed ID: 1420496
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of once weekly erythropoietin therapy in children on continuous ambulatory peritoneal dialysis.
    Hisano S, Kaku Y, Ueda K, Onoyama K.
    Acta Paediatr Jpn; 1991 Aug; 33(4):450-4. PubMed ID: 1792903
    [Abstract] [Full Text] [Related]

  • 11. Therapy of renal anemia in children and adolescents with recombinant human erythropoietin (rHuEPO).
    Campos A, Garin EH.
    Clin Pediatr (Phila); 1992 Feb; 31(2):94-9. PubMed ID: 1544282
    [Abstract] [Full Text] [Related]

  • 12. The efficacy of erythropoietin in human immunodeficiency virus-infected end-stage renal disease patients treated by maintenance hemodialysis.
    Shrivastava D, Rao TK, Sinert R, Khurana E, Lundin AP, Friedman EA.
    Am J Kidney Dis; 1995 Jun; 25(6):904-9. PubMed ID: 7771487
    [Abstract] [Full Text] [Related]

  • 13. Once weekly versus twice weekly subcutaneous administration of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis.
    Lui SF, Law CB, Ting SM, Li P, Lai KN.
    Clin Nephrol; 1991 Nov; 36(5):246-51. PubMed ID: 1752075
    [Abstract] [Full Text] [Related]

  • 14. Recombinant human erythropoietin in anemic patients with end-stage renal disease. Results of a phase III multicenter clinical trial.
    Eschbach JW, Abdulhadi MH, Browne JK, Delano BG, Downing MR, Egrie JC, Evans RW, Friedman EA, Graber SE, Haley NR.
    Ann Intern Med; 1989 Dec 15; 111(12):992-1000. PubMed ID: 2688507
    [Abstract] [Full Text] [Related]

  • 15. Intraperitoneal administration of recombinant human erythropoietin.
    Frenken LA, Struijk DG, Coppens PJ, Tiggeler RG, Krediet RT, Koene RA.
    Perit Dial Int; 1992 Dec 15; 12(4):378-83. PubMed ID: 1420497
    [Abstract] [Full Text] [Related]

  • 16. Anemia of chronic renal failure: treatment with erythropoietin.
    Navarro M, Alonso A, Avilla JM, Espinosa L.
    Child Nephrol Urol; 1991 Dec 15; 11(3):146-51. PubMed ID: 1777893
    [Abstract] [Full Text] [Related]

  • 17. Subcutaneous recombinant human erythropoietin in chronic renal allograft dysfunction.
    Aufricht C, Marik JL, Ettenger RB.
    Pediatr Nephrol; 1998 Jan 15; 12(1):10-3. PubMed ID: 9502558
    [Abstract] [Full Text] [Related]

  • 18. The intensity of hemodialysis and the response to erythropoietin in patients with end-stage renal disease.
    Ifudu O, Feldman J, Friedman EA.
    N Engl J Med; 1996 Feb 15; 334(7):420-5. PubMed ID: 8552143
    [Abstract] [Full Text] [Related]

  • 19. Once weekly subcutaneous administration of recombinant erythropoietin in children treated with CAPD.
    Goldraich I, Goldraich N.
    Adv Perit Dial; 1992 Feb 15; 8():440-3. PubMed ID: 1361843
    [Abstract] [Full Text] [Related]

  • 20. [Effect of the treatment with human recombinant erythropoietin on anemia in children with end-stage kidney failure. French multicenter study].
    Sinnassamy P, Andre JL, Treize G, Leroy B.
    Arch Fr Pediatr; 1993 Mar 15; 50(3):201-8. PubMed ID: 8338412
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.